-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
，。、/。，，。，/PI/、、。，，。
（Pyrotech Therapeutics），、，。，，“”，，。
：
（Pyrotech Therapeutics），43，。，，。、。
：
（PyrotechTherapeutics）CEO。2006（BioDuro）。BioDuroCEOBioDuro-Sundia。
，，，。，DNA，DNA，，，。
2021312，（””）。，（AI）、Intelligence DNA（iDEL），、，。。
，。
，、、，。，，，。9，7，4IND。
，29.
4096%，。
VEGFR、FGFR、PDGFR、c-MET、PI3Kα、ERK1/2、EZH1/2、AXL、BRD4。RMX3001（）、ON101III(RMX3001、ON101，)，、。
、、。、、。
（Singlomics），。。、、。
On August 27, 2020, BeiGene and Beijing Danxue Biotechnology announced that they have reached an exclusive license agreement.
BeiGene will develop, produce and commercialize Danxue Biologics in the research of new coronaviruses globally outside of Greater China.
Neutralizing antibodies, including DXP-593 and DXP-604.
DXP-593 and DXP-604 are two new coronavirus neutralizing antibodies screened using high-throughput single-cell transcriptome and VDJ sequencing technology from more than 60 cases of new coronary pneumonia recovered antigen B cells.
Viterilon
Academician Wang Xiaodong first participated in the founding of BeiGene as a co-founder in 2010.
In 2018, Academician Wang Xiaodong and Dr.
Viterilong product pipeline
Nuocheng Jianhua
As the co-founder, Academician Shi Yigong and Dr.
The company focuses on the treatment of tumors and autoimmune diseases; as of April 1, 2021, the current market value of Nuocheng Jianhua Hong Kong stocks is about 27.
Xinkanghe Biomedicine
Xinkanghe Biomedicine, founded by Academician Dong Chen, was established in 2015.
The IL-17A/F monoclonal antibody jointly developed by Xinkanghe and Livzon Biologicals (Livvzon Bio) is currently undergoing phase 1 clinical trials in China.
In August 2020, Academician Dong Chen left Tsinghua University and joined Renji Hospital of Shanghai Jiaotong University School of Medicine.
Force Life
IONOVA LIFE SCIENCECO.
The Force team is composed of senior drug research and development scientists and business development experts.
Dr.
Weishen Pharmaceutical
Shanghai Weishen Pharmaceutical Co.
The founders of the company are: Dr.
Biaoxin Bio
Gluetacs Therapeutics relies on the "Proteolysis Targeting Drug (PROTAD)" direction of Prof.
The general manager of Biaoxin Biology is Dr.
Yang Xiaobao; former director of the Institute of Organic Chemistry of the Chinese Academy of Sciences, former deputy dean of the Shanghai Institute for Advanced Study, former director of the Institute of Immunochemistry of Shanghai University of Science and Technology, and director of the Chinese Academy of Sciences’ One Belt One Road Bangkok Center Academician Jiang Biao is one of the core figures of the company One.
Some other academician-related startups include:
Yihe Medicine: Academicians of the Royal Academy of Canada/Academy of Engineering and technical team to start a business;
Natide: Founded by the academician of the Canadian Academy of Engineering and the chief professor of Canadian nano-biomanufacturing;
Bai Mi Pharmaceutical: Academician Zhao Guoping is the core scientific consultant;
Academician Li Xiaokun, an expert in microbiology and biotechnology pharmacy, focuses on the basic theory research and new drug development of protein drugs represented by growth factors, especially the function, system theory and new drug research of fibroblast growth factor (FGFs) family proteins; and many more.
